glutamine has been researched along with mdv 3100 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blatt, EB; Bogdan, D; Buroni, L; Carreira, S; de Bono, JS; DeBerardinis, RJ; Gao, Y; Gilbreath, C; Mani, RS; Neeb, A; Parra, K; Paschalis, A; Raj, GV; Yuan, W | 1 |
1 other study(ies) available for glutamine and mdv 3100
| Article | Year |
|---|---|
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.
Topics: Androgen Receptor Antagonists; Antioxidants; Cell Line, Tumor; Drug Resistance, Neoplasm; Glutaminase; Glutamine; Humans; Male; Nitriles; Prostatic Neoplasms, Castration-Resistant; Reactive Oxygen Species; Receptors, Androgen | 2023 |